• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-05-15

  This study presents a robust, patient-specific gastric cancer assembloid platform that integrates matched tumor organoids and stromal cell subpopulations, closely recapitulating the primary tumor microenvironment. The model enables precise study of tumor–stroma interactions, drug resistance mechanisms, and personalized therapeutic response, with major implications for advancing preclinical cancer research.

• Naftifine HCl: Applied Workflows for Antifungal and FAP Rese

  2026-05-14

  Naftifine HCl, a selective allylamine antifungal agent, powers both robust topical antifungal treatment models and advanced studies on cellular signaling. This article translates recent breakthroughs into actionable protocols, troubleshooting guidance, and strategic insights for researchers targeting fungal pathogens or exploring muscle regeneration pathways.

• Midecamycin: Precision Profiling and Assay Optimization for

  2026-05-14

  Explore the scientific intricacies of Midecamycin, an acetoxy-substituted macrolide antibiotic, with an emphasis on precision assay design, resistance profiling, and application-driven protocol optimization. This article delivers in-depth guidance for leveraging Midecamycin in advanced antibacterial research beyond current literature.

• Innovations in Plant Protein Secretion Protocols and pH Sens

  2026-05-13

  The second edition of 'Plant Protein Secretion: Methods and Protocols' introduces rigorously validated, step-by-step methodologies for dissecting both conventional and unconventional protein secretion in plant cells. Its detailed protocols support high reproducibility, facilitate the study of plant-specific trafficking mechanisms, and integrate dynamic readouts such as intracellular pH measurement, advancing the field of plant cell biology.

• CDK9 Inhibitor (A3294): Protocol, Use, and Limitations

  2026-05-13

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor designed for research on transcription elongation and HIV-1 propagation. It is not appropriate for broad-spectrum CDK inhibition or studies requiring extended storage of working solutions. Researchers should adhere to recommended handling, solubility, and application guidelines.

• Latrunculin A: Reversible Inhibitor of Actin Assembly in Wor

  2026-05-12

  Latrunculin A empowers researchers to dissect actin cytoskeleton dynamics with rapid, reversible precision, enabling advanced studies in cell morphology, motility, and viral pathogenesis. This article translates recent proteomic and virology breakthroughs into actionable workflows, protocol enhancements, and troubleshooting strategies that maximize experimental clarity and reproducibility.

• Streamlining Macrolide Antibiotic Production via Gene Deleti

  2026-05-12

  This study demonstrates the targeted in-frame partial deletion of the 3-O-acyltransferase gene (sspA) in Streptomyces spiramyceticus WSJ-1, yielding a strain that produces exclusively 400-isovalerylspiramycin I. The approach reduces compositional complexity in macrolide antibiotic production, facilitating improved quality control and research into antibiotic biosynthesis and resistance.

• Cefazedone (Refosporen): Applied Workflows & Troubleshooting

  2026-05-11

  Cefazedone (Refosporen) stands out for its β-lactamase-resistant, broad-spectrum activity, enabling robust antibacterial testing and translational research. This article breaks down actionable workflows, advanced applications, and troubleshooting strategies, empowering researchers to maximize the impact of APExBIO's high-purity reagent.

• (-)-Blebbistatin: Precision Non-Muscle Myosin II Inhibition

  2026-05-11

  Leverage (-)-Blebbistatin for highly selective, reversible inhibition of non-muscle myosin II in cytoskeletal and mechanotransduction research. Unpack proven protocols, troubleshooting tips, and experimental insights that set this APExBIO tool apart for advanced cell mechanics and migration studies.

• Paclitaxel (Taxol): Optimizing Cancer Research Workflows

  2026-05-10

  Paclitaxel (Taxol) stands out as a gold-standard microtubule polymer stabilizer, enabling precise cell cycle arrest and apoptosis modeling in cancer research. This guide delivers actionable workflow enhancements, troubleshooting strategies, and translational insights from recent literature to help you achieve reproducible, high-impact results with APExBIO Paclitaxel.

• IGF2BP3 Depletion Triggers Ferroptosis in Glioma via m6A-GPX

  2026-05-09

  This study identifies the m6A reader protein IGF2BP3 as a crucial regulator of ferroptosis in glioma, acting through direct stabilization of GPX4 mRNA. Loss of IGF2BP3 leads to reduced GPX4 expression, increased ferroptosis, and impaired tumor formation, suggesting new molecular targets for glioma therapy.

• Clathrin-Mediated Endocytosis Drives Type III GCRV Entry in

  2026-05-08

  Wang et al. (2018) employed pharmacological inhibitors to elucidate the cellular entry mechanisms of type III grass carp reovirus (GCRV104). Their findings establish that GCRV104 relies on clathrin-mediated, dynamin- and pH-dependent endocytosis, with actin cytoskeleton disruption not affecting viral entry. These mechanistic insights are pivotal for developing targeted antiviral strategies and refining cell biology tools for endocytosis research.

• CGP 55845 Hydrochloride: Advanced GABAB Antagonist in Synapt

  2026-05-08

  Unlock precise control over GABAB receptor-mediated neurotransmission with CGP 55845 hydrochloride, a gold-standard antagonist for in vitro synaptic research. This guide details protocol enhancements, troubleshooting strategies, and workflow inspiration drawn from cutting-edge astrocytic GAT-3 findings, giving researchers actionable tools to probe neural circuit function.

• Cyclo (-RGDfC): Precision Tumor Targeting in Hydrogel System

  2026-05-07

  Cyclo (-RGDfC) enables high-affinity, αvβ3 integrin-selective targeting in advanced cancer models and hydrogel-based assay platforms. This guide provides actionable workflows, troubleshooting insights, and the latest experimental innovations—empowering researchers to unlock next-generation spatial control and reproducibility in integrin-mediated studies.

• Cell Surface Integrity Sets Ploidy Limits in Budding Yeast

  2026-05-07

  The reference study demonstrates that the upper ploidy limit in Saccharomyces cerevisiae is dictated by cell surface integrity rather than nuclear or genetic constraints. By experimentally generating polyploid yeast and analyzing gene expression, the researchers reveal a mechanistic link between cell membrane stress and genome content, with broad implications for understanding polyploidy tolerance.

654 records 11/44 page Previous Next First page 上5页 1112131415 下5页 Last page